Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon Paternotte

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|January 25, 2021
Real-life association between inhaler technique, patient preference and asthma control in patients with uncontrolled asthma switched to budesonide/formoterol DuoResp® Spiromax® combinationNicolas Roche, Bernard Aguilaniu, Simon Paternotte, et al.
Joint Bone Spine|July 13, 2013
Rapidly destructive tibiofemoral knee osteoarthritis: clinicoradiological presentation and outcome after global medical treatment including non-arthroscopic joint lavage plus corticosteroid injection. A single center retrolective studyVincent Burki, Simon Paternotte, Maxime Dougados, et al.
Rheumatology (Oxford, England)|June 5, 2012
Evidence of the symptomatic and structural efficacy of methotrexate in daily practice as the first disease-modifying drug in rheumatoid arthritis despite its suboptimal use: results from the ESPOIR early synovitis cohortCécile Gaujoux-Viala, Simon Paternotte, Bernard Combe, et al.
Clinical and Experimental Rheumatology|October 29, 2011
Switching between tumour necrosis factor blockers in spondyloarthritis: a retrospective monocentre study of 222 patientsSabrina Dadoun, Guillaume Geri, Simon Paternotte, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 14, 2014
Effectiveness of tumor necrosis factor α blockers in early axial spondyloarthritis: data from the DESIR cohortAnna Moltó, Simon Paternotte, Pascal Claudepierre, et al.
Annals of the Rheumatic Diseases|December 15, 2010
Validation of a numerical rating scale to assess functional impairment in hip and knee osteoarthritis: comparison with the WOMAC function scalePaul Ornetti, Maxime Dougados, Simon Paternotte, et al.
The Journal of Rheumatology|November 19, 2013
Repeated anticitrullinated protein antibody and rheumatoid factor assessment is not necessary in early arthritis: results from the ESPOIR cohortLaure Gossec, Simon Paternotte, Bernard Combe, et al.
The Journal of Rheumatology|June 5, 2013
Lumbar disc degeneration in osteoporotic men: prevalence and assessment of the relation with presence of vertebral fractureIsabelle Fabreguet, Jacques Fechtenbaum, Karine Briot, et al.
Joint Bone Spine|December 25, 2010
Influence of the experience of the reader on reliability of joint space width measurement. A cross-sectional multiple reading study in hip osteoarthritisPaul Ornetti, Jean-Francis Maillefert, Simon Paternotte, et al.
The Journal of Rheumatology|April 17, 2014
Early increase of abdominal adiposity in patients with spondyloarthritis receiving anti-tumor necrosis factor-α treatmentIhsane Hmamouchi, Christian Roux, Simon Paternotte, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|January 25, 2021
Real-life association between inhaler technique, patient preference and asthma control in patients with uncontrolled asthma switched to budesonide/formoterol DuoResp® Spiromax® combinationNicolas Roche, Bernard Aguilaniu, Simon Paternotte, et al.
Joint Bone Spine|July 13, 2013
Rapidly destructive tibiofemoral knee osteoarthritis: clinicoradiological presentation and outcome after global medical treatment including non-arthroscopic joint lavage plus corticosteroid injection. A single center retrolective studyVincent Burki, Simon Paternotte, Maxime Dougados, et al.
Rheumatology (Oxford, England)|June 5, 2012
Evidence of the symptomatic and structural efficacy of methotrexate in daily practice as the first disease-modifying drug in rheumatoid arthritis despite its suboptimal use: results from the ESPOIR early synovitis cohortCécile Gaujoux-Viala, Simon Paternotte, Bernard Combe, et al.
Clinical and Experimental Rheumatology|October 29, 2011
Switching between tumour necrosis factor blockers in spondyloarthritis: a retrospective monocentre study of 222 patientsSabrina Dadoun, Guillaume Geri, Simon Paternotte, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 14, 2014
Effectiveness of tumor necrosis factor α blockers in early axial spondyloarthritis: data from the DESIR cohortAnna Moltó, Simon Paternotte, Pascal Claudepierre, et al.
Annals of the Rheumatic Diseases|December 15, 2010
Validation of a numerical rating scale to assess functional impairment in hip and knee osteoarthritis: comparison with the WOMAC function scalePaul Ornetti, Maxime Dougados, Simon Paternotte, et al.
The Journal of Rheumatology|November 19, 2013
Repeated anticitrullinated protein antibody and rheumatoid factor assessment is not necessary in early arthritis: results from the ESPOIR cohortLaure Gossec, Simon Paternotte, Bernard Combe, et al.
The Journal of Rheumatology|June 5, 2013
Lumbar disc degeneration in osteoporotic men: prevalence and assessment of the relation with presence of vertebral fractureIsabelle Fabreguet, Jacques Fechtenbaum, Karine Briot, et al.
Joint Bone Spine|December 25, 2010
Influence of the experience of the reader on reliability of joint space width measurement. A cross-sectional multiple reading study in hip osteoarthritisPaul Ornetti, Jean-Francis Maillefert, Simon Paternotte, et al.
The Journal of Rheumatology|April 17, 2014
Early increase of abdominal adiposity in patients with spondyloarthritis receiving anti-tumor necrosis factor-α treatmentIhsane Hmamouchi, Christian Roux, Simon Paternotte, et al.
Pageof 4